Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 69 (Search time: 0.005 seconds).

No. Year Title Type
69 2021

2021Patent

암 진단 또는 치료 표적으로서 LYPD1의 용도KR10-2017-0112830 (2017.09.04) / 10-2237463 (2021.04.01)김세미; 김솔비; 이윤희
Patent
68 2021

2021Article

A new surface charge neutralizing nano-adjuvant to potentiate polymyxins in killing Mcr-1 mediated drug-resistant Escherichia coliPharmaceutics, vol. 13, no. 2, pp. 250-250H Cho; A Naskar; S LeeSemi Kim; K S Kim
Article
67 2021

2021Article

Bovine serum albumin-immobilized black phosphorus-based γ-Fe2O3 nanocomposites: a promising biocompatible nanoplatformBiomedicines, vol. 9, no. 8, pp. 858-858A Naskar; S Lee; Dongjoon Ko; Semi Kim; K S Kim
Article
66 2021

2021Article

Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progressionJournal of Pathology, vol. 253, pp. 55-67J Ryu; E Kim; M K Kang; D G Song; E A Shin; H Lee; J W Jung; S H Nam; J E Kim; H J Kim, et al.
Article
65 2021

2021Article

TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activityJournal of Experimental & Clinical Cancer Research, vol. 40, no. 1, pp. 58-58Yunhee Lee; Dongjoon Ko; Junghwa Yoon; Y H Lee; Semi Kim
Article
64 2021

2021Article

TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1Journal of Experimental & Clinical Cancer Research, vol. 40, pp. 372-372Yunhee Lee; Junghwa Yoon; Dongjoon Ko; Minyeong Yu; S LeeSemi Kim
Article
63 2020

2020Article

A nontoxic biocompatible nanocomposite comprising black phosphorus with Au?γ-Fe2O3 nanoparticlesRsc Advances, vol. 10, pp. 16162-16167A Naskar; Semi Kim; K S Kim
Article
62 2020

2020Article

A new nano-platform of erythromycin combined with Ag nano-particle ZnO nano-structure against methicillin-resistant Staphylococcus aureusPharmaceutics, vol. 12, no. 9, pp. 841-841A Naskar; S Lee; Yunhee Lee; Semi Kim; K S Kim
Article
61 2019

2019Patent

C12orf59 유래 펩타이드를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물KR10-2013-0111067 (2013.09.16) / 10-1965363 (2019.03.28)이윤희; 김세미
Patent
60 2019

2019Report

면역노화 조절인자 발굴 및 면역치료기술 개발 = Investigation of immune ageing regulator and immunotherapy연구책임자 : 최인표 / 주관부처 : 미래창조과학부최인표윤석란김태돈김세미정해용조이숙이희구조희준
Report
59 2019

2019Article

Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4Scientific Reports, vol. 9, pp. 10003-10003Solbi Kim; Dongjoon Ko; Yunhee Lee; S Jang; Y Lee; I Y Lee; Semi Kim
Article
58 2019

2019Article

Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 SignalingCell Metabolism, vol. 29, no. 6, pp. 1306-1319J W Jung; S J Y Macalino; M Cui; J E Kim; H J Kim; D G Song; S H Nam; Semi Kim; S Choi; J W Lee
Article
57 2018

2018Patent

C12orf59 유래 펩타이드를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물FR15160116.8 (2015.03.20) / 3069727 (2018.07.25)이윤희; 김세미
Patent
56 2018

2018Patent

C12orf59 유래 펩타이드를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물DE15160116.8 (2015.03.20) / 3069727 (2018.07.25)이윤희; 김세미
Patent
55 2018

2018Patent

C12orf59 유래 펩타이드를 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물GB15160116.8 (2015.03.20) / 3069727 (2018.07.25)이윤희; 김세미
Patent
54 2018

2018Patent

TM4SF5에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도CH13824875.2 (2015.03.02) / 2886556 (2018.03.29)김세미; 송진명; 민혜진; 김상직
Patent
53 2018

2018Patent

TM4SF5에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도CN201380052088.5 (2015.04.03) / ZL201380052088.5 (2018.03.06)김세미; 송진명; 민혜진; 김상직
Patent
52 2018

2018Patent

TM4SF5에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도FR13824875.2 (2015.03.02) / 2886556 (2018.03.01)김세미; 송진명; 민혜진; 김상직
Patent
51 2018

2018Patent

카르보닐기 환원효소 1 단백질의 발현 또는 활성 억제제를 포함하는 대장암 예방, 치료 또는 전이 억제용 약학적 조성물KR10-2012-0140350 (2012.12.05) / 10-1834485 (2018.02.26)이윤희; 김세미
Patent
50 2018

2018Patent

TM4SF5에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도GB13824875.2 (2015.03.02) / 2886556 (2018.02.08)김세미; 송진명; 민혜진; 김상직
Patent
1 2 3 4